It’s not easy to get depression-detecting AI through the FDA

Kintsugi, a California startup, spent seven years developing AI to detect depression and anxiety by analyzing how someone speaks rather than what they say. The company is shutting down after failing to get FDA (Food and Drug Administration, the U.S. agency that approves medical products) clearance, though it is releasing its technology as open-source software so others can use and build on it.